Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Large-scale testing (Phase 3)Active Not RecruitingNCT03057054
What this trial is testing

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmLeukemia+1 more
Children's Oncology Group 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT05643638
What this trial is testing

CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD

Who this might be right for
Graft Versus Host Disease, Acute
Cynata Therapeutics Limited 60
Early research (Phase 1)Study completedNCT00825487
What this trial is testing

Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies

Who this might be right for
Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 50
Testing effectiveness (Phase 2)Ended earlyNCT04220632
What this trial is testing

IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Who this might be right for
GVHD,Acute
Innovent Biologics (Suzhou) Co. Ltd. 1
Large-scale testing (Phase 3)Ended earlyNCT05263999
What this trial is testing

Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Who this might be right for
Graft Versus Host DiseaseGVHDAcute-graft-versus-host Disease+2 more
Equillium 158
Early research (Phase 1)Looking for participantsNCT06750133
What this trial is testing

Universal CNK-UT Therapy for Refractory aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University 23
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Testing effectiveness (Phase 2)Study completedNCT00144703
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Who this might be right for
Hematologic MalignanciesMyelogenous LeukemiaAcute Lymphoblastic Leukemia+3 more
Dana-Farber Cancer Institute 55
Not applicableStudy completedNCT04882605
What this trial is testing

KIR Sequencing and Typing for Allograft in Nancy

Who this might be right for
Stem Cell Transplant Complications
Central Hospital, Nancy, France 156
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Not applicableStudy completedNCT07048730
What this trial is testing

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

Who this might be right for
Acute Leukemia
University Hospital, Bordeaux 51
Testing effectiveness (Phase 2)Study completedNCT00520130
What this trial is testing

Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

Who this might be right for
Myelodysplastic SyndromeHodgkin's LymphomaNon-Hodgkin's Disease+2 more
National Cancer Institute (NCI) 92
Early research (Phase 1)Active Not RecruitingNCT07576010
What this trial is testing

Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft-versus-host Disease
Daihong Liu 30
Testing effectiveness (Phase 2)UnknownNCT01941394
What this trial is testing

Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation

Who this might be right for
Graft-versus-host DiseaseRelapse
National Research Center for Hematology, Russia 70
Testing effectiveness (Phase 2)UnknownNCT06279494
What this trial is testing

Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesSevere Aplastic Anemia
Peking University People's Hospital 6
Testing effectiveness (Phase 2)Study completedNCT02208037
What this trial is testing

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 279
Testing effectiveness (Phase 2)UnknownNCT02799888
What this trial is testing

Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

Who this might be right for
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Affiliated Hospital to Academy of Military Medical Sciences 40
Large-scale testing (Phase 3)Ended earlyNCT00926575
What this trial is testing

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

Who this might be right for
Acute Gastrointestinal Graft vs Host Disease
Soligenix 140
Next Page